𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Oral bisphosphonates and risk of ischemic stroke: a case–control study

✍ Scribed by S. Christensen; F. Mehnert; R. D. Chapurlat; J. A. Baron; H. T. Sørensen

Publisher
Springer-Verlag
Year
2010
Tongue
English
Weight
136 KB
Volume
22
Category
Article
ISSN
0937-941X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of ischemic stroke in patients with
Risk of ischemic stroke in patients with Crohn's disease: A population-based nested case-control study
✍ Frank Andersohn; Mark Waring; Edeltraut Garbe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 2 views

## Background: Observational studies have linked crohn's disease (cd) to an increased risk of venous thromboembolic complications. case reports of ischemic stroke in cd patients have raised the question of a similar association, but data from observational studies are lacking. ## Methods: Using d

Arterial ischemic stroke risk factors: T
Arterial ischemic stroke risk factors: The international pediatric stroke study
✍ Mark T. Mackay; Max Wiznitzer; Susan L. Benedict; Katherine J. Lee; Gabrielle A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

## Abstract ## Objective To describe presumptive risk factors (RFs) for childhood arterial ischemic stroke (AIS) and explore their relationship with presentation, age, geography, and infarct characteristics. ## Methods Children (29 days–18 years) were prospectively enrolled in the International

Hematocrit and stroke. A case-control st
Hematocrit and stroke. A case-control study
✍ O. Ponari; M. Squeri; A. Mombelloni; A. Catamo; S. Tardio; G. Moretti 📂 Article 📅 1984 🏛 Springer Milan 🌐 English ⚖ 181 KB
Exposure to bisphosphonates and risk of
Exposure to bisphosphonates and risk of colorectal cancer : A population-based nested case-control study
✍ Harminder Singh; Zoann Nugent; Alain Demers; Salaheddin Mahmud; Charles Bernstei 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 792 KB

## Abstract ## BACKGROUND: Chemoprevention is a potentially attractive strategy for decreasing the burden of colorectal cancer (CRC). Preclinical studies suggest that bisphosphonates (BPs) may have direct antitumour effects against CRC. The objective of this study was to determine the effect of ex